Physician profile
Simone Straw
NPI 1861486821
$1,636.91
in general payments reported to CMS, 2019-2025
14 companies · $416 in 2025
The $416 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $125 · 2021: $341 · 2022: $170 · 2023: $196 · 2024: $203 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $564.65 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $318.98 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Sanofi Pasteur INC. | $278.99 | 2019-2025 | |
| Cranial Technologies, INC | $89.78 | 2019-2024 | Doc Band |
| Sobi, INC | $70.98 | 2019-2021 | |
| Qiagen, LLC | $49.40 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $49.25 | 2025 | Neffy |
| Seqirus USA INC | $48.39 | 2022-2025 | Flucelvax |
| Kaleo, INC. | $45.81 | 2019-2024 | Auvi-Q |
| Alk-Abello, INC | $35.94 | 2025 | Neffy |
| Genentech USA, INC. | $28.64 | 2021 | |
| Alexion Pharmaceuticals, INC. | $23.47 | 2025 | Koselugo |
| Astrazeneca Pharmaceuticals Lp | $20.70 | 2024 | Flumist Quadrivalent |
| Aytu Biopharma, INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Straw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.